This company listing is no longer active
Virtus Health Future Growth
Future criteria checks 0/6
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Healthcare earnings growth | 24.7% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
Virtus Health (ASX:VRT) Will Pay A Dividend Of AU$0.12
Mar 03What Is Virtus Health Limited's (ASX:VRT) Share Price Doing?
Dec 14Slowing Rates Of Return At Virtus Health (ASX:VRT) Leave Little Room For Excitement
Jun 03Is Now An Opportune Moment To Examine Virtus Health Limited (ASX:VRT)?
May 14Virtus Health Limited's (ASX:VRT) Intrinsic Value Is Potentially 73% Above Its Share Price
Apr 13Here's Why Virtus Health (ASX:VRT) Can Manage Its Debt Responsibly
Mar 29Is Virtus Health Limited (ASX:VRT) Popular Amongst Institutions?
Mar 17Virtus Health Limited's (ASX:VRT) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?
Mar 05Some Investors May Be Willing To Look Past Virtus Health's (ASX:VRT) Soft Earnings
Feb 22What Do The Returns On Capital At Virtus Health (ASX:VRT) Tell Us?
Feb 16Virtus Health (ASX:VRT) Shareholders Have Enjoyed A 23% Share Price Gain
Jan 26Need To Know: Virtus Health Limited (ASX:VRT) Insiders Have Been Buying Shares
Jan 05What Type Of Shareholders Own The Most Number of Virtus Health Limited (ASX:VRT) Shares?
Dec 13Is Virtus Health (ASX:VRT) A Risky Investment?
Nov 25There Is A Reason Virtus Health Limited's (ASX:VRT) Price Is Undemanding
Aug 13How Much Are Virtus Health Limited (ASX:VRT) Insiders Spending On Buying Shares?
Jul 29What Does Virtus Health Limited's (ASX:VRT) Share Price Indicate?
Jul 14In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Virtus Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2021 | 335 | 28 | 40 | 54 | N/A |
9/30/2021 | 335 | 36 | 46 | 60 | N/A |
6/30/2021 | 334 | 43 | 51 | 66 | N/A |
3/31/2021 | 315 | 29 | 57 | 70 | N/A |
12/31/2020 | 296 | 15 | 62 | 75 | N/A |
9/30/2020 | 282 | 8 | 60 | 71 | N/A |
6/30/2020 | 268 | 0 | 58 | 66 | N/A |
3/31/2020 | 275 | 15 | 48 | 57 | N/A |
12/31/2019 | 282 | 29 | 39 | 47 | N/A |
9/30/2019 | 282 | 29 | 31 | 43 | N/A |
6/30/2019 | 281 | 28 | 24 | 38 | N/A |
3/31/2019 | 276 | 29 | 22 | 39 | N/A |
12/31/2018 | 271 | 29 | 20 | 39 | N/A |
9/30/2018 | 268 | 30 | 30 | 47 | N/A |
6/30/2018 | 264 | 31 | 39 | 55 | N/A |
3/31/2018 | 261 | 30 | 41 | 54 | N/A |
12/31/2017 | 259 | 30 | 42 | 53 | N/A |
9/30/2017 | 258 | 29 | 36 | 46 | N/A |
6/30/2017 | 257 | 28 | 29 | 39 | N/A |
3/31/2017 | 258 | 29 | 31 | 41 | N/A |
12/31/2016 | 260 | 30 | 34 | 43 | N/A |
9/30/2016 | 261 | 31 | 36 | 46 | N/A |
6/30/2016 | 261 | 33 | 38 | 48 | N/A |
3/31/2016 | 257 | 32 | 33 | 44 | N/A |
12/31/2015 | 252 | 31 | 29 | 40 | N/A |
9/30/2015 | 243 | 30 | N/A | 40 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if VRT's forecast earnings growth is above the savings rate (1.8%).
Earnings vs Market: Insufficient data to determine if VRT's earnings are forecast to grow faster than the Australian market
High Growth Earnings: Insufficient data to determine if VRT's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if VRT's revenue is forecast to grow faster than the Australian market.
High Growth Revenue: Insufficient data to determine if VRT's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if VRT's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2022/08/07 00:27 |
End of Day Share Price | 2022/08/01 00:00 |
Earnings | 2021/12/31 |
Annual Earnings | 2021/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Virtus Health Limited is covered by 11 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Russell Wright | Barclay Pearce Capital Pty Limited |
John Hester | Bell Potter |
David Stanton | CLSA |